The Pill That Moves the Needle

Learn More

Explore the history and impact of the rapidly growing $30 billion global vaccines market.

Our platform supports the rapid development, manufacture and distribution of vaccines.

Explore our development programs.

News & Press

10/26/21

Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vacci..

10/07/21

New Duke University-led Study Shows That Vaxart's Oral COVID-19 V..

10/06/21

Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Table..